Yahoo Web Search

Search results

  1. Principal Investigator. Christopher Sturgeon, Ph.D. After completing his Ph.D. under the supervision of Michel Roberge at the University of British Columbia in Vancouver, Chris moved to Toronto for his postdoctoral studies with Gordon Keller.

  2. The Sturgeon Lab is focused on understanding hematopoietic development, using both human pluripotent stem cells (hPSCs) and model organisms, to develop novel cell-based therapeutics. We have many ongoing projects, specifically focused on the development of hematopoietic stem cells (HSCs), natural killer (NK) cells, B cells, or macrophages.

    • Christopher Sturgeon1
    • Christopher Sturgeon2
    • Christopher Sturgeon3
    • Christopher Sturgeon4
    • Christopher Sturgeon5
  3. Christopher Sturgeon, PhD. About Me. The goal of my research is to understand how the hematopoietic system develops during embryogenesis. I am particularly fascinated by the role transient developmental programs play in establishing lifelong hematopoiesis, and the heterogeneity found within these cells.

  4. Christopher M. Sturgeon's 38 research works with 1,400 citations and 2,550 reads, including: Haematopoietic stem and progenitor cell heterogeneity is inherited from the embryonic...

  5. August 1, 2020 Christopher Sturgeon The Sturgeon lab has found a new home at the Icahn School of Medicine at Mount Sinai. We are working as part of the Black Family Stem Cell Institute in order to continue our research.

  6. May 8, 2013 · Christopher M Sturgeon, Andrea Ditadi, Raedun L Clarke & Gordon Keller. Nature Biotechnology 31 , 416–418 ( 2013) Cite this article. 8747 Accesses. 38 Citations. 1 Altmetric. Metrics. New...

  7. Dr. Sturgeon is an Associate Professor at the Icahn School of Medicine at Mount Sinai. His studies focus on characterizing the signal pathways that control human pluripotent stem cell differentiation towards hematopoietic stem/progenitors and how this impacts natural killer (NK) cell development and function.